MAFA anticorps (C-Term)
Aperçu rapide pour MAFA anticorps (C-Term) (ABIN953280)
Antigène
Voir toutes MAFA AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 285-315, C-Term
-
Specificité
- This antibody recognizes Human MAFA (C-term).
-
Purification
- Protein A column, followed by peptide affinity purification
-
Immunogène
- KLH conjugated synthetic peptide between 285-315 amino acids from the C-terminal region of human MAFA
-
Isotype
- Ig Fraction
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.25 mg/mL
-
Buffer
- PBS containing 0.09 % (W/V) Sodium Azide as preservative
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Avoid repeated freezing and thawing.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- MAFA (Transcription Factor MafA (MAFA))
-
Autre désignation
- MAFA
-
Sujet
- MAFA is a transcription factor that binds RIPE3b, a conserved enhancer element that regulates pancreatic beta cell-specific expression of the insulin gene (INS, MIM 176730) (Olbrot et al., 2002 [PubMed 12011435]).Synonyms: Pancreatic beta-cell-specific transcriptional activator, Transcription factor MafA, Transcription factor RIPE3b1, V-maf musculoaponeurotic fibrosarcoma oncogene homolog A
-
Poids moléculaire
- 36982 Da
-
ID gène
- 389692
-
NCBI Accession
- NP_963883
-
Pathways
- Hormone Transport
Antigène
-